Author:
Ohno Ryuzo,Kimura Kiyoji,Amaki Ichita,Hirano Masami,Hoshino Akira,Ikeda Yasushi,Kimura Ikuro,Kobayashi Masahide,Konno Kiyoshi,Majima Hisashi,Masaoka Toru,Mizuno Harumitsu,Ogawa Makoto,Oguro Masao,Saito Tatuo,Shimoyama Masanori,Shirakawa Shigeru,Sugawara Yuzuru,Takaku Fumimaro,Yamada Hideo,Yamada Kazumasa,Yamagata Kaoru,Yoshida Yutaka,Yoshikawa Satoshi,Wakui Akira,
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference30 articles.
1. Blum RH (1975) An overview of studies with adriamycin (NSC-123127) in the United States. Cancer Chemothr Rep 6: 247?251
2. Blum RH, Carter SK (1974) Adriamycin. A new anticancer drug with significant clinical activity. Ann Intern Med 80: 149?259
3. Boiron M, Jacquillat C, Weil M, Tanzer J, Levy D, Sultan C, Bernard J (1969) Daunorubicin in the treatment of acute myelocytic leukaemia. Lancet I: 330?333
4. Bonadonna G, Monfardini S, Lena MD, Fossa-Bellani F, Beretta G (1970) Phase I and preliminary phase II evaluation of adriamycin (NCS-123127) Cancer Res 30: 2572?2582
5. Bornstein RS, Theologides A, Kennedy BJ (1969) Daunorubicin in acute myelogenous leukemia in adults. J Am Med Assoc 207: 1301?1306
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献